Profile
International Journal of Clinical & Medical Microbiology Volume 1 (2016), Article ID 1:IJCMM-115, 2 pages
https://doi.org/10.15344/2456-4028/2016/115
Commentary
[Pasteurella] pneumotropica as a Potential Mouse Infection Model for Assessment of Substantial Opportunistic Bacterial Infections

Hiraku Sasaki1*, Hidehiro Ueshiba2, Eiichi Kawamoto3 and Ron Boot4

1Laboratory of Microbiology and Hygiene, Department of Health Science, School of Health and Sports Science, Juntendo University, Inzai, Chiba 270-1695, Japan
2Institute of Laboratory Animals, Tokyo Women’s Medical University, Shinjuku, Tokyo 162-8666, Japan
3Animal Research Center, Tokyo Medical University, Shinjuku, Tokyo 160-8402, Japan
4National Institute of Public Health and the Environment, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, the Netherlands
Dr. Hiraku Sasaki, Laboratory of Microbiology and Hygiene, Department of Health Science, School of Health and Sports Science, Juntendo University, 1-1, Hiragagakuendai, Inzai, Chiba 270-1695, Japan, Tel: +81-476-98-1001; E-mail: hirakus@juntendo.ac.jp
24 November 2016; 17 December 2016; 19 December 2016
Sasaki H, Ueshiba H, Kawamoto E, Boot R (2016) [Pasteurella] pneumotropica as a Potential Mouse Infection Model for Assessment of Substantial Opportunistic Bacterial Infections. Int J Clin Med Microbiol 1: 115. doi: https://doi.org/10.15344/2456-4028/2016/115

[Pasteurella] pneumotropica (Pp) is a gram-negative respiratory pathogen that commonly colonizes laboratory rodent species. Infected immunocompetent animals exhibit no clinical signs; however, this bacterium can cause a broad range of infections in immunodeficient and immunosuppressed rodents, from relatively mild diseases to lifethreatening pneumonia [1]. Thus, infections caused by Pp are an issue in the management of laboratory rodents.

Recently, the draft genome sequences of Jawetz and Heyl biotypes of Pp has been reported [2,3]. With respect to putative virulenceassociated genes possibly involved in pathogenicity, hemagglutinins, adhesins, hemolysins, type VI secretion proteins, RTX exoproteins [4,5], and outer membrane components were identified in both biotypes of Pp. Almost all of these factors have been biologically and molecularly characterized in human or animal pathogens.

In immunocompetent mice, Pp colonizes the oral cavity, upper respiratory tract, conjunctiva, intestines, and vagina without typical clinical signs. According to Patten et al. [6], chronic infection caused by Pp induced upregulation of selected inflammatory cytokines in C57BL/6 mice. Against that background, Pp infection might be considered a robust model to study bacterial infections in mice. Coinfection of severe acute respiratory syndrome coronavirus and Pp induced exacerbated pneumonia in mice, resembling that found in humans [7]. Further, there are no endodontic pathogens specific for laboratory rodents, and therefore oral Pp infection is used as a mouse endodontic model [8]. Similarly, the oral infection caused by the bacterium that is genetically related to Pp is suggested to be a potential periodontitis in a murine ligature-induced disease model [9].

Immunological studies showed that recombinant outer membrane proteins (OMPs) homologous to the OMPs of Haemophilus influenzae protected mice from pneumonia [10]. Multiple intranasal immunizations with recombinant PnxIIIA protein successfully elicited PnxIIIA-specific secretory IgA and defended mice against opportunistic infection by Pp [11]. These studies not only focused on prevention of Pp infection in mice but also on a broad perspective of vaccination strategies as a countermeasure against important human opportunistic pathogens.

The Pp infection model has become a substantial infection model for assessment of responsible infectious agents in mice, even though there are still issues to be addressed. For instance, diversified genetic and biochemical properties of Pp in wild-type strains, and in particular, the significant differences in various characteristics between mouse and rat isolates [12-14] might make this model unsuitable for studies, depending on experimental conditions. Furthermore, some virulence factors associated with the host pathophysiology are not exhaustively identified. These relationships involving strain diversity and bacterial virulence need to be clarified in future studies.

In general, Pp is the causative agent of rodent pasteurellosis; however, Pp infections have been reported in various hosts, including humans and non-rodent organisms. Either of these cases were thought to be based on misclassification due to the commercial systems for identification. In any cases,the isolates were assumed to be identified as Pp or closely related species in Pasteurellaceae. Cases of systemic or local infection caused by Pp or Pp-like pathogens in humans with underlying diseases, who have contact with household pets, have been described [15,16]. Even though Pp is usually considered an exceptional human pathogen, reported cases suggest that its ability to infect humans should not be underestimated.

Competing Interests

The author declare that there is no competing interests regarding the publication of this article.


References

  1. Kawamoto E, Sasaki H, Okiyama E, Kanai T, Ueshiba H, et al. (2011) Pathogenicity of Pasteurella pneumotropica in immunodeficient NOD/ ShiJic-scid/Jcl and immunocompetent Crlj:CD1 (ICR) mice. Exp Anim 60: 463-470 [CrossRef] [Google Scholar] [PubMed]
  2. Sasaki H, Ishikawa H, Asano R, Ueshiba H, Matsumoto T, et al. (2014) Draft Genome Sequence of the Rodent Opportunistic Pathogen Pasteurella pneumotropica ATCC 35149T. Genome Announc 2: e00771-14 [CrossRef] [Google Scholar] [PubMed]
  3. Sasaki H, Ishikawa H, Terayama H, Asano R, Kawamoto E, et al. (2016) Identification of a virulence determinant that is conserved in the Jawetz and Heyl biotypes in [Pasteurella] pneumotropica. Pathog Dis 74: ftw066 [CrossRef] [Google Scholar] [PubMed]
  4. Sasaki H, Ishikawa H, Sato T, Sekiguchi S, Amao H, et al. (2011) Molecular and virulence characteristics of an outer membrane-associated RTX exoprotein in Pasteurella pneumotropica. BMC Microbiol 11: 55 [CrossRef] [Google Scholar] [PubMed]
  5. Sasaki H, Kawamoto E, Tanaka Y, Sawada T, Kunita S, et al. (2009) Identification and characterization of hemolysin-like proteins similar to RTX toxin in Pasteurella pneumotropica. J Bacteriol 191: 3698-3705 [CrossRef] [Google Scholar] [PubMed]
  6. Patten CC Jr, Myles MH, Franklin CL, Livingston RS (2010) Perturbations in cytokine gene expression after inoculation of C57BL/6 mice with Pasteurella pneumotropica. Comp Med 60: 18-24 [Google Scholar] [PubMed]
  7. Ami Y, Nagata N, Shirato K, Watanabe R, Iwata N, et al. (2008) Coinfection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice. Microbiol Immunol 52: 118-127 [CrossRef] [Google Scholar] [PubMed]
  8. Silva MJ, Kajiya M, AlShwaimi E, Sasaki H, Hong J, et al. (2012) Bacteriareactive immune response may induce RANKL-expressing T cells in the mouse periapical bone loss lesion. J Endod 38: 346-350 [CrossRef] [Google Scholar] [PubMed]
  9. Darzi Y, Jiao Y, Hasegawa M, Moon H, Núñez G, et al. (2016) The Genomic Sequence of the Oral Pathobiont Strain NI1060 Reveals Unique Strategies for Bacterial Competition and Pathogenicity. PLoS One 11: e0158866 [CrossRef] [Google Scholar] [PubMed]
  10. See SB, Thomas WR (2013) Protective anti-outer membrane protein immunity against Pasteurella pneumotropica infection of mice. Microbes Infect 15: 470-479 [CrossRef] [Google Scholar] [PubMed]
  11. Sasaki H, Ishikawa H, Kojima K, Itoh M, Matsumoto T, et al. (2013) Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice. Vaccine 31: 5729-5735 [CrossRef] [Google Scholar] [PubMed]
  12. Boot R (2010) A Pasteurella pneumotropica strain of mouse origin colonizes rats but is out competed by a P. pneumotropica strain of rat origin. Scand J Lab Anim Sci 37: 261-265 [CrossRef] [Google Scholar]
  13. Sasaki H, Kawamoto E, Okiyama E, Ueshiba H, Mikazuki K, et al. (2006) Molecular typing of Pasteurella pneumotropica isolated from rodents by amplified 16S ribosomal DNA restriction analysis and pulsed-field gel electrophoresis. Microbiol Immunol 50: 265-272 [CrossRef] [Google Scholar] [PubMed]
  14. Sasaki H, Kawamoto E, Tanaka Y, Sawada T, Kunita S, et al. (2009) Comparative analysis of Pasteurella pneumotropica isolates from laboratory mice and rats. Antonie Van Leeuwenhoek 95: 311-317 [CrossRef] [Google Scholar] [PubMed]
  15. Rimoldi SG, Pagani C, Di Gregorio A, Palazzin A, Romano P, et al. (2016) Pasteurella spp. in knee mega prosthesis infection: a case report. Int J Clin Med Microbiol 1: 105 [CrossRef] [Google Scholar]
  16. Tirmizi A, Butt S, Molitorisz S (2012) First reported case of Pasteurella pneumotropica tricuspid valve endocarditis. Int J Cardiol 161: e44-45 [CrossRef] [Google Scholar] [PubMed]